Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

bortezomib/poly(2-hydroxyethyl methacrylate-co-dopamine methacrylamide)-functionalized Fe3O4 nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

poly(2-hydroxyethyl methacrylate-co-dopamine methacrylamide)-functionalized iron oxide nanoparticles

poly(2-hydroxyethyl methacrylate-co-dopamine methacrylamide)-functionalized Fe3O4 nanoparticles p(HEMA-co-DMA)-functionalized IONP
Type Nano Material
Formula
Role carriers
2

pyrazylcarbonyl-Phe-Leuboronate

Bortezomib bortezomib Velcade PS-341 BTZ
Type Single Compound
Formula C19H25BN4O4
Role loaded material

Properties

General physical and chemical properties

Property Value Source
drug release dependent on pH

More information available to subscribers only.

Or, view sample content

Applications

Area Application Source
medical devices

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Source
athymic Balb/c mouse

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Product

bortezomib/poly(2-hydroxyethyl methacrylate-co-dopamine methacrylamide)-functionalized Fe3O4 nanoparticles

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • poly(2-hydroxyethyl methacrylate-co-dopamine methacrylamide)
  • pyrazylcarbonyl-Phe-Leuboronate
  1. Mtr2vnUdm2N3C7BkH7yXPF0oU4
Product

bortezomib/poly(2-hydroxyethyl methacrylate-co-dopamine methacrylamide)-functionalized Fe3O4 nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial